HIC2 promotes cell cycle transitions by upregulating CDK1 expression in glioblastoma

HIC2 promotes cell cycle transitions by upregulating CDK1 expression in glioblastoma

Bibliographic Details
Main Authors:	Peifen Lu, Wenbing Shangguan, Quan Zhao
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Asian Journal of Surgery
Subjects:	Glioma Prognosis HIC2 CDK1
Online Access:	http://www.sciencedirect.com/science/article/pii/S101595842300667X

Similar Items

Diverse genetic contexts of HicA toxin domains propose a role in anti-phage defense
by: Kenn Gerdes
Published: (2024-02-01)

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
by: Yanlin Wu, et al.
Published: (2023-06-01)

MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
by: Jun-feng Zhang, et al.
Published: (2018-12-01)

Characterization of HicAB toxin-antitoxin module of Sinorhizobium meliloti
by: Manon Thomet, et al.
Published: (2019-01-01)

HIC and SSC of Carbon Steel in High Partial Pressure CO2 Environments with Elevated H2S
by: Abas Ahmad Zaki, et al.
Published: (2021-01-01)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
by: Yan Li, et al.
Published: (2019-10-01)

Does high and intensive care reduce coercion? Association of HIC model fidelity to seclusion use in the Netherlands
by: A. L. Van Melle, et al.
Published: (2020-09-01)

Identification and Characterization of the HicAB Toxin-Antitoxin System in the Opportunistic Pathogen Pseudomonas aeruginosa
by: Gang Li, et al.
Published: (2016-04-01)

Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells
by: Ubaid Ullah, et al.
Published: (2018-02-01)

Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity
by: Si Huang, et al.
Published: (2022-05-01)

Targeting CDK9 for the Treatment of Glioblastoma
by: Alice Ranjan, et al.
Published: (2021-06-01)

Long non-coding RNA LINC00473 promotes glioma cells proliferation and invasion by impairing miR-637/CDK6 axis
by: Qiansheng Zhang, et al.
Published: (2019-12-01)

Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
by: Xueqing Sun, et al.
Published: (2019-12-01)

Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy
by: Maximilian Fleischmann, et al.
Published: (2022-11-01)

PKM2 Interacts With the Cdk1-CyclinB Complex to Facilitate Cell Cycle Progression in Gliomas
by: Shigeo Ohba, et al.
Published: (2022-03-01)

ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression
by: Junqiang Liu, et al.
Published: (2022-05-01)

The Prognostic Role of CDK9 in Bladder Cancer
by: Jędrzej Borowczak, et al.
Published: (2022-03-01)

Expression of CDK9 in endometrial cancer tissues and its effect on the proliferation of HEC-1B
by: Yang Wen, et al.
Published: (2021-12-01)

Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1
by: Peng-jing Duan, et al.
Published: (2020-07-01)

A Comparative Investigation of the Corrosion Resistance and HIC Suceptibility of API 5L X65 and API 5L X80 Steels
by: Janeth Marlene Quispe-Avilés, et al.
Published: (2019-01-01)

CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
by: Wei Liu, et al.
Published: (2021-02-01)

Wilms’ tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability
by: Jingyuan Tang, et al.
Published: (2018-02-01)

CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
by: Mattia Garutti, et al.
Published: (2021-05-01)

NUCKS1 Promotes Proliferation, Invasion and Migration of Non-Small Cell Lung Cancer by Upregulating CDK1 Expression
by: Zhao S, et al.
Published: (2020-12-01)

The Effect of Automotive Side Member Filling on Car Frontal Impact Performance
by: M. S. Salwani, et al.
Published: (2014-06-01)

Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition
by: Qingyi Hu, et al.
Published: (2023-05-01)

Expression of CDK13 Was Associated with Prognosis and Expression of HIF-1α and beclin1 in Breast Cancer Patients
by: Xia-Liang Lu, et al.
Published: (2022-02-01)

CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
by: Xiao Li, et al.
Published: (2022-04-01)

Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases
by: Zengli Guo, et al.
Published: (2019-08-01)

Control of Expression of Key Cell Cycle Enzymes Drives Cell Line-Specific Functions of CDK7 in Human PDAC Cells
by: Lina Kolloch, et al.
Published: (2022-01-01)

CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer
by: Zhouying Wu, et al.
Published: (2021-08-01)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
by: Mei Zeng, et al.
Published: (2018-11-01)

CDK4/6i enhances the antitumor effect of PD1 antibody by promoting TLS formation in ovarian cancer
by: Wangyou Feng, et al.
Published: (2023-09-01)

The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
by: Emily Jiggens, et al.
Published: (2021-10-01)

HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma
by: Jin Shi, et al.
Published: (2020-03-01)

CDK5: an oncogene or an anti-oncogene: location location location
by: Kumar Nikhil, et al.
Published: (2023-11-01)

Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules
by: Marius Volker Dannappel, et al.
Published: (2019-01-01)

CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer
by: Ke-Qi Lu, et al.
Published: (2024-03-01)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
by: Finn-Ole Paulsen, et al.
Published: (2020-07-01)

CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer
by: Tobias Jagomast, et al.
Published: (2022-01-01)